Multiple drugsUrticaria following off-label use and drug eruption: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1823卷 / 1期

关键词：

D O I：

10.1007/s40278-020-83882-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：254 / 254

相关论文

共 50 条

[1] HydroxychloroquineMaculopapular eruption following off-label use: 6 case reports
[J]. Reactions Weekly, 2022, 1913 (1) : 240 - 240
[2] TrametinibAcneiform eruption following off-label use: 3 case reports
[J]. Reactions Weekly, 2020, 1830 (1) : 300 - 300
[3] TrametinibPapulopustular eruption following off-label treatment: 2 case reports
[J]. Reactions Weekly, 2020, 1835 (1) : 361 - 361
[4] Multiple drugsLack off efficacy following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1910 (1) : 335 - 335
[5] Multiple drugsLack of efficacy following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1907 (1) : 333 - 333
[6] Multiple drugsLack of efficacy following off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1872 (1) : 351 - 351
[7] ClozapineAgranulocytosis following off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1924 (1) : 164 - 164
[8] FavipiravirDisseminated erythematous drug eruption following an off-label use: case report
[J]. Reactions Weekly, 2023, 1982 (1) : 188 - 188
[9] BebtelovimabAnaphylaxis following off-label use: 2 case reports
[J]. Reactions Weekly, 2023, 1954 (1) : 113 - 113
[10] FerumoxytolNausea following off-label use: 2 case reports
[J]. Reactions Weekly, 2017, 1650 (1) : 142 - 142

← 1 2 3 4 5 →